Clinical trials recruiting in Zhenzhou, China

Phase breakdown

Conditions recruiting in Zhenzhou, China

Recruiting trials in Zhenzhou, China

• A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
  NCT07143045 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
  NCT07299825 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
  NCT05590871 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female)
• Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
  NCT04930432 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Zhenzhou, China?

4 recruiting trials have at least one study site in Zhenzhou, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.